ONCOVALUE project to automate data collection and analytics in assessing real-life effectiveness of cancer care
Picture: Antoni van Leeuwenhoek/NKI
Funded by the EU and coordinated by Helsinki University Hospital (HUS), the ONCOVALUE project is building a seamless and automated method to support evaluating the effectiveness of novel cancer therapies. The project brings together six leading European cancer hospitals and three technology companies.
Reliable and comparable data on the real-life effectiveness of treatments
Project Manager Nea Hellman from HUS outlines the goals of the project: "The main goal of this four-year project is to collect, as comprehensively and promptly as possible, real-world data (RWD) stored in the patient information systems of European cancer hospitals, thus obtaining reliable information on the real-life effectiveness of cancer therapies given to patients. The project aims to develop a standardised and automated way of collecting information so that it is reliable, consistent and comparable across the hospitals involved in the project."
The research mainly focuses on drug therapies for breast cancer and lung cancer. The project combines patient data on clinical outcomes, patient-reported quality of life, and costs on the patient group-level for analysis. The methods developed in the project can also be applied to other types of cancer and, at best, can accelerate the introduction of novel, effective cancer medications. On the other hand, patient groups that do not benefit from treatment can be identified, which allows therapies to be targeted to those who will truly benefit from them. With the general cost pressures in healthcare, it is important to know the real benefits of medications for patients.
Data collection supported by artificial intelligence and machine learning
The aim of the methods developed in the project are to record information in patient information systems in a standardised manner and to collect it automatically into a data pool for further analysis. The project is developing ways to gather data with the help of artificial intelligence and machine learning, both from structured data (structured data fields, e.g. from the patient information system Apotti) and unstructured data (e.g. free-text medical statements or radiological images).
The projects work packages also work on examining the regulatory requirements and guidelines for studying and sharing real-world data and the related ethics requirements and legislation. The development of this area is also being followed closely.
Pioneers in the field involved in co-research
Under the leadership of HUS, leading European cancer hospitals and commercial businesses are participating in the research work of the ONCOVALUE project. Six academic hospitals are involved in conducting impactful research. For example, consortium partner Netherlands Cancer Institute (NKI) has strong expertise in Health Technology Assessment (HTA), while Rigshospitalet plays a central role in developing standards and guidelines related to structured data together with HUS and other partners. The CleverHealth Network ecosystem partners, such as pharmaceutical companies, could potentially be contacted in evaluating the project's results.
Siemens Healthineers has brought its expertise to the project, including Artificial Intelligence technology for automatic interpretation of radiological images. The project is studying computed tomography images on breast and lung cancer patients, aiming to assess the disease progression fully automatically from a series of follow-up images. "The ability to automatically quantify how much metastases are growing or shrinking under different therapies will unlock new insights and add an additional layer of robustness and accuracy to the analysis of real-world data," says Tobias Heimann, Head of Artificial Intelligence Germany, from Siemens Healthineers.
BC Platforms, on the other hand, is involved in a work package related to the use and sharing of real-world data, where a federated model is being built to analyse data related to cancer therapies. The federated model in this project is based on harmonizing data to the Observational Medical Outcomes Partnership (OMOP) common data model. Data is harmonised so that information from different hospitals can be compared to each other without aggregating it. One of the main barriers to the efficient use of real-world data has been the lack of a standardised data model, which complicates data sharing between registries.
“BC Platforms supports the ONCOVALUE initiative via federated technology and data analysis as well as reporting tools for RWD reporting in real time. BC Platforms hopes that this consortium will lead to better, more environmentally sustainable therapies, technologies, and digital solutions for cancer care,” says Anni Ahonen-Bishopp, Director, Discovery & Research Platform.
Aiming for a replicable model
The ONCOVALUE project has now reached a stage where a federated model is being constructed for sharing patient group-level data, in which it is impossible to link the information back to individual patients. The model being built during the ONCOVALUE project is intended for research purposes, with the aim that a similar model could later be built to production use. The goal is that eventually, this federated model can provide information, for example, on the real-life efficacy of a particular drug from several different hospitals, thus providing a broader knowledge base for decision-making.
In conclusion, Nea Hellman says: "The methods developed in the project can be used to improve the operations of the Comprehensive Cancer Center, structured data entry, and structuring data utilizing artificial intelligence. We also aim to narrow the gap between research work and day-to-day patient care and to develop the ways real-world data is produced and used. I believe that the methods built in the ONCOVALUE project will be replicable in the future for evaluating the treatments of other diseases as well."
ONCOVALUE consortium partners:
HUS Helsinki University Hospital (FI), Stichting Het Nederlands Kanker Instituut-Anton (NL), STICHTING RIJNSTATE ZIEKENHUIS (NL), Elevate BV (NL), IQVIA Solutions BV (NL), Rigshospitalet Copenhagen University Hospital (DK), BC Platforms LTD OY (FI), Siemens Healthcare AG (GER), Instituto Portugues de Oncologia do Porto (PT), Istituto Romagnolo per lo Studio deiTumori "Dino Amadori" (IT), CIAOTech Srl (IT), TTOPSTART BV (NL).
ONCOVALUE coordination team from HUS:
· Johanna Mattson, Scientific & Clinical lead
· Pekka Kahri, Coordinator
· Nea Hellman, Project manager
· Samu Eränen, WP1 lead
· Sami Pakarinen, WP5 lead
· Mikko Juvonen, Technical lead
· Anne Kemppainen, Financial controller
Read more: https://ONCOVALUE.org/
- 15.08.2024 12:50
Medtronic joins CleverHealth Network ecosystem - 19.06.2024 13:49
CleverHealth Network collaboration between HUS and Fujitsu moves dialysis from hospitals to homes - 06.05.2024 14:27
eMOM project has been completed with promising findings in helping mothers to manage their gestational diabetes - 06.05.2024 13:56
The PHEMS EU project promotes the use of pediatric healthcare data between hospitals - 31.01.2024 11:44
ONCOVALUE project to automate data collection and analytics in assessing real-life effectiveness of cancer care - 26.01.2024 13:33
Impressive results, new ideas and interaction at the CleverHealth Network annual seminar - 02.11.2023 12:35
New remote care solution improves patients' quality of life and brings significant savings to society - 22.09.2023 10:26
A graduate thesis within CleverHealth Network studied the cost-effectiveness of clinical support system for diagnosing vasculitis - 22.08.2023 15:06
Acute leukemia project shows great results in optimizing oncology diagnostic and treatment automation - 22.05.2023 09:24
AstraZeneca joins the CleverHealth Network ecosystem - 03.05.2023 14:47
Tackling pandemics event brings latest results from virus diagnostics to creating health safe spaces - 27.04.2023 09:25
Hewlett Packard Enterprise joins CleverHealth Network - 30.01.2023 10:54
CleverHealth Network ecosystem of digital health innovations yields significant results - 07.12.2022 12:23
Significant EU funding for implementing value-based cancer care at European cancer hospitals - 07.10.2022 09:20
Finnish opera singers contribute to E3 project in detecting differences between people as emitters of aerosols - 10.06.2022 14:28
CleverHealth Network ecosystem and E3 Excellence in Pandemics Response project showcased at HIMSS22 Europe - 18.05.2022 14:25
HUS Acamedic is a certified and scalable virtual research and analytics environment for secure processing of health data - 14.03.2022 09:00
CleverHealth Network showcased at HIMSS Global Health Conference 2022 in March - 17.02.2022 07:37
Novartis is the new partner in the CleverHealth Network ecosystem - 10.12.2021 13:11
Finland must renew its forerunner position in healthcare interoperability - 25.11.2021 14:09
The pandemic boosted the multidisciplinary E3 project on indoor health safety - 11.11.2021 09:51
Telia joins the CleverHealth Network ecosystem - 28.10.2021 10:29
Siemens Healthineers joins the CleverHealth Network collaboration - 04.10.2021 10:43
Fujitsu Finland co-develops a digital service to support treatment of gestational diabetes - 27.05.2021 16:27
Health technology research seeks for tools to support the daily life of dialysis patients and their care personnel - 04.05.2021 17:54
Close collaboration around algorithms in the AI Head Analysis project - 27.04.2021 16:07
Planmeca brings their expertise to CleverHealth Network's AI Head Analysis project focusing on early detection of cerebral hemorrhages - 06.04.2021 10:00
Roche the newest partner of CleverHealth Network - 26.03.2021 16:14
Mobile application to treat gestational diabetes - 01.02.2021 10:30
New preventive care for cardiac disease patients - 21.12.2020 15:00
News on novel initiatives and progress of ecosystem projects were shared at the CleverHealth Network event - 01.12.2020 15:01
Kimmo Porkka's project team harnesses the latest technologies to implement personalised therapies - 05.11.2020 15:30
Smart applications for home dialysis help the daily life of dialysis patients and medical staff - 15.06.2020 15:17
CleverHealth Network ecosystem projects are moving forward - 13.03.2020 13:00
Home dialysis for better quality of life and more efficient treatment - 05.03.2020 15:43
CleverHealth Network projects facilitate diagnostic reliability and improve patient safety - 19.02.2020 15:31
CleverHealth Network wants to start new projects – Pfizer latest partner to join the ecosystem - 27.01.2020 13:00
Fresh media coverage of CleverHealth Network - 24.01.2020 10:49
Networking event in December 2019 was a success - 29.11.2019 13:00
Finnish ecosystem of health innovations continues to grow - 29.08.2019 13:00
CleverHealth Network participated, for the first time, in the HIMSS & Health 2.0 conference organized in Messukeskus, Helsinki 11–13 June 2019. - 10.06.2019 15:00
Digital health innovation ecosystem CleverHealth Network granted Growth Engine status and significant additional funding - 17.04.2019 09:00
Faster and more effective care through artificial intelligence - 28.02.2019 12:45
Aiming for easy and safe remote glucose monitoring for diabetic children - 05.12.2018 15:54
HUS recognised for healthcare IT ecosystem - 01.12.2018 15:00
AI-based diagnostic tool to examine cerebral hemorrhage - 07.03.2018 13:43
AI application for treatment of gestational diabetes - 19.09.2017 17:11
Launching a new ecosystem of digital health innovations